Skip to main content

Fluocinolone News

Related terms: Fluocinolone Topical, Fluocinolone Otic

ANI Pharmaceuticals Announces FDA Approval for Expansion of Iluvien Label

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) – ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an...

FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis

WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) – EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative...

FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis

WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) – EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative...

FDA Approves Iluvien for Diabetic Macular Edema

WATERTOWN, Mass.--(BUSINESS WIRE)-- pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the U.S. Food and Drug...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Diabetic Macular Edema

Fluocinolone patient information at Drugs.com